// changes done below on July 01 2024 // till here on July 01 2024

mRNA Synthesis and Manufacturing Market Revenue to Cross USD 0.58 billion by 2035

Published: April 2024


According to a recently published report by Roots Analysis, the growing demand of mRNA-based drugs (vaccines and therapeutics) and ongoing technological advancements are driving the mRNA synthesis and manufacturing market

mRNA Synthesis and Manufacturing Industry Overview

The global mRNA Synthesis and Manufacturing Market is anticipated to reach USD 0.58 billion by 2035.

Messenger ribonucleic acid (mRNA) has emerged as one of the key therapeutic modalities in the modern healthcare industry. It carries genetic information from the DNA to ribosomes, for the production of functional proteins. The benefits of mRNA technology involves rapid development cycle, versatility and scalability; further, its success came to the forefront during the COVID-19 pandemic, with the development of mRNA vaccines (namely COMIRNATY and Spikevax). It is worth highlighting that the ongoing research has expanded the therapeutic applications of mRNA beyond infectious diseases, to autoimmune disorders, genetic disorders and oncological disorders. Notably, an innovation in the mRNA domain involves the development of advanced nanoparticle delivery systems, in order to protect mRNA molecules, increase cellular update and enable targeted delivery. However, the process of mRNA manufacturing is itself a challenging process, therefore, various companies rely on the contract manufacturing organizations for their support in the mRNA / mRNA-based drugs production.

Browse 95+ figures and 80+ market data tables spread across 170+ pages and detailed Table of Content on “mRNA Synthesis and Manufacturing Market Industry Trends and Global Forecasts, till 2035 by Purpose of Syringe, Distribution by Type of Product (Drug Substance (APIs) and Drug Product (FDFs)), Application Area (mRNA-based Vaccines and mRNA-based Therapeutics), Therapeutic Area (Infectious Diseases, Oncological Disorders and Other Disorders), and Key Geographical Regions (North America, Europe, Asia-Pacific and Rest of the World)” here: https://www.rootsanalysis.com/reports/mrna-synthesis-and-manufacturing-market.html

Market Drivers

Given the growing demand for mRNA-based vaccines and therapies, the market for mRNA synthesis and manufacturing is anticipated to grow significantly over the coming years. Notably, the success of mRNA-based COVID-19 vaccines has been a major contributor to  this industry. Further,  the reliance on service providers for mRNA synthesis and manufacturing is likely to increase in the coming years to leverage their specialized facilities, advanced technologies and methodologies, streamlined processes, and well-versed operational and regulatory expertise.

Market Restraints

While the mRNA synthesis and manufacturing market is experiencing substantial growth, there are certain restraints that can hinder the growth of the industry. One of the major factors is the disruption / shortage in the supply of raw materials that impact mRNA production. Further, mRNA molecules are inherently unstable and require specific temperature conditions (for storage and delivery), thereby adding complexity to the supply chain. Notably, ensuring the quality and purity of mRNA products is crucial (which involves strict adherence to regulatory guidelines); any lapse in quality control processes can lead to batch rejections or recalls.

Growth Factors

Despite the aforementioned challenges, various growth factors continue to drive the mRNA synthesis and manufacturing market forward. One of the primary factors includes the ongoing technological advancements (including synthesis methods, purification techniques and delivery systems) that enhance efficiency, reduce costs and allow development of novel therapeutics. Further, the rising prevalence of chronic disorders fuels the demand for mRNA therapeutics and vaccines, for targeted and personalized treatments. Notably, increased partnerships between pharmaceutical firms and research institutes foster collaborative efforts to jointly tackle challenges and explore new avenues in the mRNA synthesis and manufacturing market.

mRNA Synthesis and Manufacturing Market Segments

Based on the type of product, the market is segmented into drug substances and drug products.

  • The drug substances segment captures the largest revenue share (close to 65%) in the mRNA synthesis and manufacturing market, in 2024.

Based on the application area, the market is segmented into mRNA-based vaccines and mRNA-based therapeutics.

  • Currently, mRNA vaccines drive the mRNA synthesis and manufacturing market. However, we anticipate the approval of mRNA-based therapeutics in the coming few years.

Based on the therapeutic area, the market is segmented into infectious diseases, oncological disorders and other disorders.

  • The infectious diseases segment captures the largest revenue share (100%) in the mRNA synthesis and manufacturing market, in 2024. However, in the next decade, oncological disorders are likely to grow at a faster pace in this market.

Based on the Regional Insights, the market is segmented North America, Europe, Asia-Pacific and Rest of the World

  • North America segment captures the largest revenue share (close to 50%) in the mRNA synthesis and manufacturing market, in 2024.

Key Companies Profiled

The mRNA synthesis and manufacturing market report also includes detailed profiles of key players (listed below) that offer services for synthesis and manufacturing of mRNA:

  • Aldevron
  • APExBIO
  • Aurigene Pharmaceutical Services
  • Biomay
  • CELLSCRIPT
  • Curia
  • eTheRNA
  • Enzynomics
  • Eurogentec
  • Genscript
  • Jena Bioscience
  • Merck KGaA
  • New England Biolabs
  • Vernal Biosciences
  • ST Pharm
  • Thermo Fisher Scientific
  • TriLink BioTechnologies 
  • WuXi Biologics

You Can Download Free Sample PDF Copy Of This Report At:
https://www.rootsanalysis.com/reports/mrna-synthesis-and-manufacturing-market/request-sample.html

About Roots Analysis

Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. All reports provided by us are structured in a way that enables the reader to develop a thorough perspective on the given subject. Apart from writing reports on identified areas, we provide bespoke research / consulting services dedicated to serve our clients in the best possible way.

Contact Details

Gaurav Chaudhary
+1 (415) 800 3415
+44 (122) 391 1091
Email: Gaurav.chaudhary@rootsanalysis.com or sales@rootsanalysis.com

MEDIA CITATIONS

  • We are your partners with no equity

  • We fit in your budget

  • We love what we do

  • Chance to prove ourselves

  • Best in class quality of work

  • Most trusted consulting partner in the industry